Allergy/Imm

Your Article Summary

See Latest Articles

Is the Interruption of Antiretroviral Treatment During Pregnancy an Additional Major Risk Factor for Mother-to-Child Transmission of HIV Type 1
Clinical Infectious Diseases, 04/03/09

Galli L et al. - Discontinuing ART during pregnancy increases the rate of mother-to-child transmission of HIV-1, either when ART is stopped in the first trimester and subsequently restarted or when it is interrupted in the third trimester. This finding supports recommendations to continue ART in pregnant women who are already receiving treatment for their health.

Today in HIV/Immunodeficiency...keeping you current

Receive free subspecialty "5-minute updates" via email

Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
Malaria Journal, 12/01/09

Minimum infective dose of HIV for parenteral dosimetry
International Journal of STD & AIDS, 12/01/09

Horizontally-acquired HIV infection in Kenyan and Swazi children
International Journal of STD & AIDS, 12/01/09

 See all of HIV/Immunodeficiency

Today in Maternal Fetal Medicine...keeping you current

Receive free subspecialty "5-minute updates" via email

Complement Activation and Pregnancy Failure
Clinical Reviews in Allergy and Immunology, 12/01/09

Role of Tissue Factor in the Maternal Immunological Attack of the Embryo in the Antiphospholipid Syndrome
Clinical Reviews in Allergy and Immunology, 12/01/09

Systemic Increase in the Ratio between Foxp3+ and IL-17-Producing CD4+ T Cells in Healthy Pregnancy but Not in Preeclampsia
Journal of Immunology, 12/01/09

 See all of Maternal Fetal Medicine